secwatch / observer
8-K filed July 24, 2025, 7:59 PM ET ticker TLSI CIK 0001826667
other material confidence high sentiment neutral materiality 0.75

TriSalus completes Preferred Stock exchange; 98.82% tendered at 3.3 common shares each

TriSalus Life Sciences, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

TriSalus Life Sciences, Inc.: Amended Certificate of Designations for Series A Convertible Preferred Stock to permit mandatory conversion upon closing of the exchange offer (effective 2025-07-24).

Change
charter amendment
Effective
2025-07-24
Exact text from the filing
on July 24, 2025, the Company filed the Preferred Stock Amendment with the Secretary of State of the State of Delaware. The Preferred Stock Amendment will permit the Company to require that all shares of Preferred Stock that are outstanding upon the closing of the Offer be converted into the number of shares of Common Stock equal to the quotient of (i) the sum of (a) the Liquidation Preference (as defined in the Certificate of Designations (defined below)) and (b) the Accrued Dividends (as defined in the Certificate of Designations) if not otherwise paid by the Company, that would have accrued through closing the Offer (the “Exchanged Value”), divided by the Conversion Price (as defined in the Certificate of Designations, as such term will be amended by the Preferred Stock Amendment.
View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

TriSalus Life Sciences, Inc. filing history →

Source: SEC EDGAR
accession 0001826667-25-000103
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.